Literature DB >> 3812014

Space orientation of total hip prosthesis. A method for three-dimensional determination.

K Herrlin, G Selvik, H Pettersson.   

Abstract

A method for in vivo determination of orientation and relation in space of components of total hip prosthesis is described. The method allows for determination of the orientation of the prosthetic components in well defined anatomic planes of the body. Furthermore the range of free motion from neutral position to the point of contact between the edge of the acetabular opening and the neck of the femoral component can be determined in various directions. To assess the accuracy of the calculations a phantom prosthesis was studied in nine different positions and the measurements of the space oriented parameters according to the present method correlated to measurements of the same parameters according to Selvik's stereophotogrammetric method. Good correlation was found. The role of prosthetic malpositioning and component interaction evaluated with the present method in the development of prosthetic loosening and displacement is discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3812014     DOI: 10.1177/028418518602700602

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  3 in total

1.  Hip-spine relationship: a radio-anatomical study for optimization in acetabular cup positioning.

Authors:  J-Y Lazennec; N Charlot; M Gorin; B Roger; N Arafati; A Bissery; G Saillant
Journal:  Surg Radiol Anat       Date:  2003-11-07       Impact factor: 1.246

Review 2.  Radiographic assessment of the cup orientation after total hip arthroplasty: a literature review.

Authors:  Jing-Xin Zhao; Xiu-Yun Su; Zhe Zhao; Ruo-Xiu Xiao; Li-Cheng Zhang; Pei-Fu Tang
Journal:  Ann Transl Med       Date:  2020-02

Review 3.  Acetabular cup position and risk of dislocation in primary total hip arthroplasty.

Authors:  Kurt G Seagrave; Anders Troelsen; Henrik Malchau; Henrik Husted; Kirill Gromov
Journal:  Acta Orthop       Date:  2016-11-23       Impact factor: 3.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.